DISCUSSION: Competition Commission probes high cancer drug pricing

June 14, 2017 4:41 am

Yesterday the CompetitionCommission announced that it is opening an investigation on pharmaceutical companies, Roche Holdings, pharmaceutical giant Pfizer and Aspen Pharmacare for alleged excessive cancer drug pricing. In May 2017 the European Union also opened a formal investigation into concerns that Aspen Pharma has engaged in excessive pricing concerning five life-saving cancer medicines.

For more news, visit: http://www.sabc.co.za/news

Related Articles

Tags: , , , , ,

Categorised in:

Do NOT follow this link or you will be banned from the site!